Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Allergologia Et Immunopathologia|August 3, 2016
Matrix effect on baked milk tolerance in children with IgE cow milk allergyS Miceli Sopo, M Greco, S Monaco, et al.
Neurobiology of Aging|August 4, 2005
Cortical rhythms reactivity in AD, LBD and normal subjects: a quantitative MEG studyR Franciotti, D Iacono, S Della Penna, et al.
American Journal of Hematology|August 6, 1998
Predictive parameters for mobilized peripheral blood CD34+ progenitor cell collection in patients with hematological malignanciesG D'Arena, P Musto, L Di Mauro, et al.
Clinical & Experimental Metastasis|June 19, 2013
Risk factors and survival outcomes in patients with brain metastases from breast cancerA M Minisini, S Moroso, L Gerratana, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 28, 2003
Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-upM Onofrj, A Thomas, G D'Andreamatteo, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Ribosome biogenesis is a therapeutic vulnerability in paediatric neuroblastomaCamille Jouines, Piero Lo Monaco, Angéline Gaucherot, et al.
European Journal of Applied Physiology|November 21, 2024
The reliability of functional and systemic markers of muscle damage in response to a flywheel squat protocolTrevor J Dufner, Alexandria D Iacono, Jacob R Wheeler, et al.
Allergologia Et Immunopathologia|October 15, 2018
Cooking influence in tolerance acquisition in egg-induced acute food protein enterocolitis syndromeS Miceli Sopo, A Romano, G Bersani, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
ItaLynch: an ongoing Italian study to evaluate the feasibility of mainstreaming the diagnosis of Lynch syndrome in colorectal cancer patientsA Puccini, F Grillo, M Fassan, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
HER-2 gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM studyD Ciardiello, L Boscolo Bielo, S Napolitano, et al.
Pageof 3